Your Health: May 15, 2000


CANCER CARE It's not easy to say something positive when there's a diagnosis of advanced ovarian cancer. But researchers have found that women with the hereditary form of the disease may survive an average of two years longer than those with no genetic predisposition. The same defect on either the BRCA1 or BRCA2 gene that makes women vulnerable to the cancer may also make them more responsive to chemotherapy. Once researchers figure out why, they may be able to develop more effective treatments for both forms of the disease.

EROS ENVY Tired of men having all the fun? The...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!